Live
- OU celebrates National Library Week with book exhibition
- Prakash Utsav to be celebrated today
- Survey staff turn a blind eye towards apartment dwellers
- Assembly to resolve on Constitutional amendment on age limit for legislators
- Govt to hold three public meetings for ‘People’s Govt—Victory Celebrations’
- SBI staff’s presence of mind averts digital arrest scam
- Students of Rockwoods School showcase unity in diversity
- Minister demands establishment of regional Centre of Excellence
- State secured Rs 36K crore investments in 10 months, created 51K jobs: Sridhar Babu
- AI Model Detects Residual Brain Tumors in 10 Seconds, Offers Real-Time Surgical Guidance
Gene delivery system may prevent vision loss
Researchers have developed gene- carrying nanoparticles that home in on target cells and prevent vision loss in animal models of an inherited eye disease which is also one of the most common causes of blindness in children.
​New York: Researchers have developed gene- carrying nanoparticles that home in on target cells and prevent vision loss in animal models of an inherited eye disease which is also one of the most common causes of blindness in children.
Though this research, published in the journal Molecular Therapy - Nucleic Acids, focused on the form of the disease called Leber congenital amaurosis 2, or LCA2, the scientists and engineers involved in the study believe the technology holds promise for other forms of LCA as well as other inherited diseases that lead to severe vision loss or blindness.
"We believe this technology can deliver almost any type of gene to tackle inherited visual disorders," said lead researcher Zheng-Rong Lu, Professor at Case Western Reserve University in Cleveland, Ohio, US.
Those with LAC2 carry a mutated RPE65 gene and suffer from profound vision loss from birth.The mutated gene fails to produce RPE65 protein in the retinal pigment epithelium (RPE), a cell layer critical for protecting photoreceptors (rods and cones).
The protein is an essential constituent of the visual cycle that converts light to electrical signals to the brain. Lu and colleagues designed a lipid-based nanoparticle called ECO to deliver healthy RPE65 genes to RPE cells.
"The promise of this technology is it localises the drug to the photoreceptor cells, sparing the liver and kidney from exposure," Krzysztof Palczewski from the Case Western Reserve School of Medicine said.
Following injection into the retina of mice, the researchers could see fluorescent green concentrating in RPE cells.
